2.

Drug and growth factor used in tissue engineering for cardiovascular purposes

Drug/growth factor	Biomaterial
Dexamethasone	Poly(D,L-lactic-co-glycolic acid) (PLGA) [89]
PLGA microspheres/poly(vinyl alcohol) hydrogel composite [40]
VEGF	Poly(lactide-co-glycolide) (PLG) [109]
Fibrin [222]
Collagen [223]
Gelatine [224]
Alginate [114]
PDGF-BB b-FGF	Poly(D,L-lactic-co-glycolic acid) (PLGA) [71] Alginate [69]
poly(D,L-lactic-co-glycolic acid) (PLGA) [132]
Poly(ester urethane)urea [73]
Fibrin [225]
Gelatine [226]
TGF-β	Gelatine [227]
Insulin-like growth factor 1	Self-assembling nanofibres [134]
HGF	Gelatine [228]
Heparin	Alginate [81]
Chitosan [82]
Hyaluronic acid [83]
Poly(D,L-lactic-co-glycolic acid) (PLGA) [80]
Heparin	Poly(epsilon-caprolactone)(PCL) [9]
Polymer-coated metallic wires [139]
Diazeniumdiolates nitric oxide donor	Polyurethane [143]
Polyethylene glycol (PEG) [146]
Plasmid DNA encoding platelet-derived growth factor (PDGF) gene	Poly(D,L-lactic-co-glycolic acid) (PLGA) [180]